Elon Musk's Neuralink receives approval from Health Canada to perform the first trial outside of the U.S. of its brain-computer implant and robot technology.
Members of the healthcare navigation and pharmacy benefits company will have access to Curai for virtual urgent care 24/7 via the Rightway app.
The money will be used to develop new medications and biologicals.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
Also, an Indian startup has raised $1 million in seed funding to develop dental nanorobots.
The company will use the funds to drive product development, strategic account management and market growth.
The platform interprets patient responses into structured data and more efficiently finds responses that address patient needs like food insecurity or transportation barriers.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
The funds will be used to enhance its technology, expand its partnership with payers and providers, scale its reach and accelerate clinical research through enrollment support.
The partnership improves data-sharing capabilities between physical and mental health providers by allowing Array's practitioners to access patients' medical records.
